Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease
- PMID: 34630107
- PMCID: PMC8497569
- DOI: 10.3389/fphar.2021.729950
Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease
Abstract
Alcoholic liver disease (ALD) is one of the leading causes of morbidity among adults with alcohol use disorder (AUD) worldwide. Its clinical course ranges from steatosis to alcoholic hepatitis, progressing to more severe forms of liver damage, such as cirrhosis and hepatocellular carcinoma. The pathogenesis of ALD is complex and diverse elements are involved in its development, including environmental factors, genetic predisposition, the immune response, and the gut-liver axis interaction. Chronic alcohol consumption induces changes in gut microbiota that are associated with a loss of intestinal barrier function and inflammatory responses which reinforce a liver damage progression triggered by alcohol. Alcohol metabolites such as acetaldehyde, lipid peroxidation-derived aldehyde malondialdehyde (MDA), and protein-adducts act as liver-damaging hepatotoxins and potentiate systemic inflammation. Additionally, ethanol causes direct damage to the central nervous system (CNS) by crossing the blood-brain barrier (BBB), provoking oxidative stress contributing to neuroinflammation. Overall, these processes have been associated with susceptibility to depression, anxiety, and alcohol craving in ALD. Recent evidence has shown that probiotics can reverse alcohol-induced changes of the microbiota and prevent ALD progression by restoring gut microbial composition. However, the impact of probiotics on alcohol consumption behavior has been less explored. Probiotics have been used to treat various conditions by restoring microbiota and decreasing systemic and CNS inflammation. The results of some studies suggest that probiotics might improve mental function in Alzheimer's, autism spectrum disorder, and attenuated morphine analgesic tolerance. In this sense, it has been observed that gut microbiota composition alterations, as well as its modulation using probiotics, elicit changes in neurotransmitter signals in the brain, especially in the dopamine reward circuit. Consequently, it is not difficult to imagine that a probiotics-based complementary treatment to ALD might reduce disease progression mediated by lower alcohol consumption. This review aims to present an update of the pathophysiologic mechanism underlying the microbiota-gut-liver-brain axis in ALD, as well as to provide evidence supporting probiotic use as a complementary therapy to address alcohol consumption disorder and its consequences on liver damage.
Keywords: alcohol addiction; alcohol craving; alcoholic liver disease; gut-liver-brain axis; microbiota; neuroinflammation; probiotics.
Copyright © 2021 Fuenzalida, Dufeu, Poniachik, Roblero, Valenzuela-Pérez and Beltrán.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Compound Probiotic Ameliorates Acute Alcoholic Liver Disease in Mice by Modulating Gut Microbiota and Maintaining Intestinal Barrier.Probiotics Antimicrob Proteins. 2023 Feb;15(1):185-201. doi: 10.1007/s12602-022-10005-x. Epub 2022 Dec 2. Probiotics Antimicrob Proteins. 2023. PMID: 36456838
-
Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota.Front Med (Lausanne). 2022 Jul 22;9:913842. doi: 10.3389/fmed.2022.913842. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35935787 Free PMC article. Review.
-
Alcohol, liver disease and the gut microbiota.Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):235-246. doi: 10.1038/s41575-018-0099-1. Nat Rev Gastroenterol Hepatol. 2019. PMID: 30643227 Review.
-
Targeting the gut barrier for the treatment of alcoholic liver disease.Liver Res. 2017 Dec;1(4):197-207. doi: 10.1016/j.livres.2017.12.004. Liver Res. 2017. PMID: 30034913 Free PMC article.
-
Are Probiotics Effective in Targeting Alcoholic Liver Diseases?Probiotics Antimicrob Proteins. 2019 Jun;11(2):335-347. doi: 10.1007/s12602-018-9419-6. Probiotics Antimicrob Proteins. 2019. PMID: 29687200
Cited by
-
Standard rodent diets differentially impact alcohol consumption, preference, and gut microbiome diversity.Front Neurosci. 2024 May 13;18:1383181. doi: 10.3389/fnins.2024.1383181. eCollection 2024. Front Neurosci. 2024. PMID: 38803684 Free PMC article.
-
The gut-liver axis in fatty liver disease: role played by natural products.Front Pharmacol. 2024 Apr 15;15:1365294. doi: 10.3389/fphar.2024.1365294. eCollection 2024. Front Pharmacol. 2024. PMID: 38686320 Free PMC article. Review.
-
Potential Molecular Mechanisms of Alcohol Use Disorder with Non-Coding RNAs and Gut Microbiota for the Development of Superior Therapeutic Application.Genes (Basel). 2024 Mar 29;15(4):431. doi: 10.3390/genes15040431. Genes (Basel). 2024. PMID: 38674366 Free PMC article. Review.
-
Gut microbiome in alcohol use disorder: Implications for health outcomes and therapeutic strategies-a literature review.World J Methodol. 2024 Mar 20;14(1):88519. doi: 10.5662/wjm.v14.i1.88519. eCollection 2024 Mar 20. World J Methodol. 2024. PMID: 38577203 Free PMC article. Review.
-
Gut-Liver-Brain Axis and Alcohol Use Disorder: Treatment Potential of Fecal Microbiota Transplantation.Alcohol Res. 2024 Feb 1;44(1):01. doi: 10.35946/arcr.v44.1.01. eCollection 2024. Alcohol Res. 2024. PMID: 38322428 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources